Journal Article Research Support, Non-U.S. Gov't Ppublish 66 citations
PubMed: 32126932 DOI: 10.1089/thy.2019.0592
A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
Thyroid 30(7):999-1007
Authors: Anna M Sawka, Sangeet Ghai, Tom Yoannidis, Lorne Rotstein, Patrick J Gullane, Ralph W Gilbert, Jesse D Pasternak, Dale H Brown, Antoine Eskander, John R de Almeida, Jonathan C Irish, Kevin Higgins, Danny J Enepekides, Eric Monteiro, Avik Banerjee, Manish Shah, Everton Gooden, Afshan Zahedi, Mark Korman, Shereen Ezzat, Jennifer M Jones, Valeria E Rac, George Tomlinson, Aleksandra Stanimirovic, Amiram Gafni, Nancy N Baxter, David P Goldstein
Affiliations
- Division of Endocrinology, University Health Network and University of Toronto, Toronto, Canada.
- Joint Department of Medical Imaging, University Health Network-Mt Sinai Hospital-Women's College Hospital, University of Toronto, Toronto, Canada.
- Department of Otolaryngology-Head and Neck Surgery, University Health Network, Toronto, Canada.
- Department of Surgery, University Health Network and University of Toronto, Toronto, Canada.
- Department of Otolaryngology-Head and Neck Surgery/Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Canada.
- Department of Otolaryngology and Head and Neck Surgery, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Canada.
- Department of Otolaryngology and Head and Neck Surgery, Mount Sinai Hospital and University of Toronto, Toronto, Canada.
- Department of Otolaryngology and Head and Neck Surgery, Grand River Hospital Corporation, Kitchener, Canada.
- Department of Otolaryngology and Head and Neck Surgery, North York General Hospital and University of Toronto, Toronto, Canada.
- Division of Endocrinology, Women's College Hospital, Mount Sinai Hospital and University of Toronto, Toronto, Canada.
- Department of Otolaryngology and Head and Neck Surgery, William Osler Health System and University of Toronto, Brampton, Canada.
- Division of Endocrine Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
- Department of Psychosocial Oncology, University Health Network and University of Toronto, Toronto, Canada.
- Ted Rogers Centre for Heart Research at Peter Munk Cardiac Centre, Toronto General Hospital Research Institute (TGHRI), University Health Network (UHN), Toronto, Canada.
- Institute of Health Policy, Management and Evaluation (IHPME), Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
- Toronto Health Economics and Technology Assessment Collaborative, Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
- Department of Medicine University Health Network and Mount Sinai Hospital and Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
- Department of Health Research Methods, Evaluation and Implementation, Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, Canada.
- Department of Surgery, St. Michael's Hospital and University of Toronto, Toronto, Canada.
Abstract
Active surveillance (AS) of small, low-risk papillary thyroid cancers (PTCs) is increasingly being considered. There is limited understanding of why individuals with low-risk PTC may choose AS over traditional surgical management. We present a mixed-methods analysis of a prospective observational real-life decision-making study regarding the choice of thyroidectomy or AS for management of localized, low-risk PTCs <2 cm in maximum diameter (NCT03271892). Patients were provided standardized medical information and were interviewed after making their decision (which dictated disease management). We evaluated patients' levels of decision-self efficacy (confidence in medical decision-making ability) at the time information was presented and their level of decision satisfaction after finalizing their decision (using standardized questionnaires). We asked patients to explain the reason for their choice and qualitatively analyzed the results. We enrolled 74 women and 26 men of mean age 52.4 years, with a mean PTC size of 11.0 mm (interquartile range 9.0, 14.0 mm). Seventy-one patients (71.0% [95% confidence interval 60.9-79.4%]) chose AS over surgery. Ninety-four percent (94/100) of participants independently made their own disease management choice; the rest shared the decision with their physician. Participants had a high baseline level of decision self-efficacy (mean 94.3, standard deviation 9.6 on a 100-point scale). Almost all (98%, 98/100) participants reported high decision satisfaction. Factors reported by patients as influencing their decision included the following: perceived risk of thyroidectomy or the cancer, family considerations, treatment timing in the context of life circumstances, and trust in health care providers. In this Canadian study, ∼7 out of 10 patients with small, low-risk PTC, who were offered the choice of AS or surgery, chose AS. Personal perceptions about cancer or thyroidectomy, contextual factors, family considerations, and trust in health care providers strongly influenced patients' disease management choices.
MeSH
Trust, Thyroid Cancer, Papillary, Disease Management, Thyroid Diseases, Neoplasms, Thyroid Gland, Decision Making, Health Personnel, Thyroid Neoplasms, Thyroidectomy, Thyroid Hormones
Cited by
- Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery? J Cancer, 2024
- A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer. Front Endocrinol (Lausanne), 2021
- Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review. Thyroid, 2022
- Hearing the Voices of Australian Thyroid Cancer Survivors: Qualitative Thematic Analysis of Semistructured Interviews Identifies Unmet Support Needs. Thyroid, 2023
- Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation. BMC Cancer, 2021
- Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting. J Otolaryngol Head Neck Surg, 2021
- The impact of delayed diagnosis and treatment due to COVID-19 on Australian thyroid cancer patients: a qualitative interview study. BMJ Open, 2024
- Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience. Thyroid Res, 2023
- Assessing the Rise in Papillary Thyroid Cancer Incidence: A 38-Year Australian Study Investigating WHO Classification Influence. J Epidemiol Glob Health, 2025
- Propensity analysis reveals survival disparities between T1a and T1b well-differentiated thyroid cancer based on surgery. Gland Surg, 2025
- Decision-making in Surgery or Active Surveillance for Low Risk Papillary Thyroid Cancer During the COVID-19 Pandemic. Cancers (Basel), 2021
- Thermal Ablation for Papillary Thyroid Carcinoma. JAMA Otolaryngol Head Neck Surg, 2024
- Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Thyroid, 2020
- Ultrasound in active surveillance for low-risk papillary thyroid cancer: imaging considerations in case selection and disease surveillance. Insights Imaging, 2021
- Treatment Choices in Managing Bethesda III and IV Thyroid Nodules: A Canadian Multi-institutional Study. OTO Open, 2021
- Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma. Endocrinol Metab (Seoul), 2022
- Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey. Ann Surg, 2022
- Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study. Thyroid, 2024
- High-risk habitat radiomics model based on ultrasound images for predicting lateral neck lymph node metastasis in differentiated thyroid cancer. BMC Med Imaging, 2025
- Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival. Front Endocrinol (Lausanne), 2021